Skip to main content

Pomerantz Roger

Director | President And CEO

2 companies

Pomerantz Roger is a President And CEO at Seres Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 21 sells.

Estimated insider holdings value: $1.0M based on current market prices.

Holdings by Company

MCRBSep 7, 2018
Current Shares214.0K
Value$1.03M
Net Activity-824,466
Bought: 0Sold: 824.5K
VIRXNov 25, 2024
Current Shares126.5K
Est. Value-
Net Activity0
Bought: 0Sold: 0

Transaction History

Showing 10 filings
DateTickerRoleTypeSharesPriceValueChg%SEC
Sep 7, 2018
MCRB
Seres Therapeutics, Inc.
President And CEOSell1,810$9.00$16,291.27-0.8%
Sep 6, 2018
MCRB
Seres Therapeutics, Inc.
President And CEOSell12,518$9.10$113,949.53-2.8%
Jul 11, 2018
MCRB
Seres Therapeutics, Inc.
President And CEOSale+OE1,010$9.01$9,098.99-0.4%
Jul 10, 2018
MCRB
Seres Therapeutics, Inc.
President And CEOSale+OE32,336$9.12$295,065.31-4.5%
Jun 29, 2018
MCRB
Seres Therapeutics, Inc.
President And CEOSale+OE26,056$9.15$238,290.73-5.4%
Jun 27, 2018
MCRB
Seres Therapeutics, Inc.
President And CEOSale+OE64,967$9.16$595,045.43-8.7%
Jun 22, 2018
MCRB
Seres Therapeutics, Inc.
President And CEOSell85,536$9.28$793,906.79-9.5%
May 9, 2018
MCRB
Seres Therapeutics, Inc.
President And CEOSell233$9.00$2,097.00-
Jul 27, 2016
MCRB
Seres Therapeutics, Inc.
President And CEOSale+OE20,000$35.00$700,000.00-9.8%
Jul 6, 2016
MCRB
Seres Therapeutics, Inc.
President And CEOSale+OE88,211$29.45$2,597,473.97-10.4%
Page 1Next →